Benziodarone

DB13277ApprovedWithdrawnSmall molecule

Benziodarone is a uricostatic and a uricosuric agent which is sold also under the name Amplivex-Labaz. It is used in the treatment of gout . It was withdrawn from France... It was withdrawn from France markets and British markets due to its effects causing Jaundice in patients.

Chemical structure of Benziodarone
Mechanism
Curator reviewed
Formula / weight
C17H12I2O3 · 518.089 g/mol (avg)
Code names
L 2329

Resolves to

Compound
UNII75CL65GTYRCAS68-90-6ChEMBLCHEMBL232201ChEBI135814
Clinical / RWD
ATCC01DX04ATCC01DX54
Structure
InChIKeyCZCHIEJNWPNBDE-UHFFFAOYSA-NSMILESCCC1=C(C(=O)C2=CC(I)=C(O)C(I)=C2)C2=CC=CC=C2O1
Targets
P0DP23CALM1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
568Drug interactionsStructured to mechanism, not free text
Sign in
2ATC codesIncluding every combination product, plus 8 drug categories
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Benziodarone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In